Michigan-based Breeze Smoke is asking the US Supreme Court to stay a Food and Drug Administration (FDA) marketing denial order (MDO) after the Court of Appeals for the Sixth Circuit recently decided not to grant its motion because the company “has not shown a strong likelihood of success on the merits”.
The Court of Appeals ruled that “the FDA reasonably concluded that Breeze Smoke’s application did not meet the TCA’s [Tobacco Control Act] requirements that new tobacco products be appropriate for the protection of the public health”.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.